As an innovative and award-winning scientific leader with over 25 years of experience in the pharmaceutical and biotech industries, I have a broad understanding of non-clinical and clinical development landscapes, and I have worked across various therapeutic areas, including antivirals, metabolic and liver diseases, immunology, oncology, CNS, pulmonary, and ophthalmology.

In addition to my professional roles, I provide scientific advice to start-ups and consult on RNA therapeutics for investment purposes. I also serve as a monitor and expert reviewer for the European Commission, evaluating Horizon 2020 projects and Horizon Europe proposals in virology. 

My expertise spans small molecules, biologics, nucleic acid technology, and live biotherapeutic products.